ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
19
Frequently Asked Questions
What is Market Cap of ABVC BioPharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. ABVC BioPharma Inc market cap is $64.03M.
What is the 52-week high for ABVC BioPharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. ABVC BioPharma Inc 52 week high is $5.48 as of September 05, 2025.
What is the 52-week low for ABVC BioPharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. ABVC BioPharma Inc 52 week low is $0.40 as of September 05, 2025.
What is ABVC BioPharma Inc stock price today?
ABVC BioPharma Inc stock price today is $2.65.
What was ABVC BioPharma Inc stock price yesterday?
ABVC BioPharma Inc stock price yesterday was $2.72.
What is the PE ratio of ABVC BioPharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. ABVC BioPharma Inc’s P/E ratio is -14.73.
What is the Price-to-Book ratio of ABVC BioPharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. ABVC BioPharma Inc P/B ratio is 7.5753.
What is the 50-day moving average of ABVC BioPharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. ABVC BioPharma Inc 50-day moving average is $3.08.
